Expanding COVID-19 Vaccine Availability: Role for Combined Orthogonal Serology Testing (COST)

Background: The persisting Coronavirus disease 2019 (COVID-19) pandemic and limited vaccine supply has led to a shift in global health priorities to expand vaccine coverage. Relying on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) molecular testing alone cannot reveal the infection pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Narasimhan, Madhusudhanan, Mahimainathan, Lenin, Araj, Ellen, Clark, Andrew E, Wilkinson, Kathleen, Yekkaluri, Sruthi, Tiro, Jasmin, Lee, Francesca M, Balani, Jyoti, Sarode, Ravi, Singal, Amit G, Muthukumar, Alagarraju
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8069830/
https://www.ncbi.nlm.nih.gov/pubmed/33924340
http://dx.doi.org/10.3390/vaccines9040376

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8069830/
https://www.ncbi.nlm.nih.gov/pubmed/33924340
http://dx.doi.org/10.3390/vaccines9040376

Ejemplares similares